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Appendix A. Longitudinal Regression Model Equations
In addition, if a significant quadratic interaction between time and the intervention was observed, then the following model was used instead: In Model 3, we allow each PFAS to have a different effect over time in each treatment group, with a three-way interaction among PFAS, treatment group, and time:
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